Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · IEX Real-Time Price · USD
0.457
+0.017 (3.86%)
At close: Jul 26, 2024, 4:00 PM
0.455
-0.002 (-0.35%)
After-hours: Jul 26, 2024, 7:59 PM EDT
Unicycive Therapeutics Revenue
In the year 2023, Unicycive Therapeutics had annual revenue of $675.00K, down -29.02%.
Revenue (ttm)
$675.00K
Revenue Growth
-29.02%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
39.16M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionUNCY News
- 10 days ago - Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO) - GlobeNewsWire
- 16 days ago - Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual Conference - GlobeNewsWire
- 17 days ago - Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC) - GlobeNewsWire
- 26 days ago - Unicycive Therapeutics Joins Russell Microcap® Index - GlobeNewsWire
- 4 weeks ago - Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial - GlobeNewsWire
- 2 months ago - Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - GlobeNewsWire
- 2 months ago - Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference - GlobeNewsWire
- 2 months ago - Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting - GlobeNewsWire